DiaMedica Therapeutics, Inc. (DMAC)
6.39
-0.36
(-5.33%)
USD |
NASDAQ |
Aug 28, 16:00
6.39
0.00 (0.00%)
After-Hours: 20:00
DiaMedica Therapeutics Total Assets (Quarterly) : 45.00M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 45.00M |
| March 31, 2026 | 53.08M |
| December 31, 2025 | 61.37M |
| September 30, 2025 | 57.05M |
| June 30, 2025 | 31.47M |
| March 31, 2025 | 38.83M |
| December 31, 2024 | 46.34M |
| September 30, 2024 | 52.52M |
| June 30, 2024 | 56.79M |
| March 31, 2024 | 49.26M |
| December 31, 2023 | 54.16M |
| September 30, 2023 | 58.14M |
| June 30, 2023 | 62.05M |
| March 31, 2023 | 30.22M |
| December 31, 2022 | 34.40M |
| September 30, 2022 | 37.04M |
| June 30, 2022 | 39.26M |
| March 31, 2022 | 42.21M |
| December 31, 2021 | 45.55M |
| September 30, 2021 | 48.66M |
| June 30, 2021 | 21.77M |
| March 31, 2021 | 24.36M |
| December 31, 2020 | 28.10M |
| September 30, 2020 | 31.27M |
| June 30, 2020 | 12.58M |
| Date | Value |
|---|---|
| March 31, 2020 | 14.36M |
| December 31, 2019 | 9.053M |
| September 30, 2019 | 11.04M |
| June 30, 2019 | 12.80M |
| March 31, 2019 | 15.49M |
| December 31, 2018 | |
| September 30, 2018 | 5.422M |
| June 30, 2018 | 6.386M |
| March 31, 2018 | 7.900M |
| December 31, 2017 | 1.818M |
| September 30, 2017 | 1.024M |
| June 30, 2017 | 1.957M |
| March 31, 2017 | 1.070M |
| December 31, 2016 | |
| September 30, 2016 | 3.115M |
| June 30, 2016 | 0.4297M |
| March 31, 2016 | 0.386M |
| December 31, 2015 | 0.2222M |
| September 30, 2015 | 0.1992M |
| June 30, 2015 | 0.5268M |
| March 31, 2015 | 0.3157M |
| December 31, 2014 | 0.2822M |
| September 30, 2014 | 0.6959M |
| June 30, 2014 | 1.725M |
| March 31, 2014 | 1.884M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.663M |
| Shareholders Equity (Quarterly) | 38.34M |
| Debt to Equity Ratio | 0.0048 |
| Current Ratio | 6.720 |
| Net Debt Paydown Yield | 0.01% |